Janssen Sued Over Diabetes Drug's Blood Disorder Risk
Johnson & Johnson unit Janssen has been hit with a lawsuit over its Type 2 diabetes drug Invokana by a man claiming that he developed the potentially life-threatening condition diabetic ketoacidosis,...To view the full article, register now.
Already a subscriber? Click here to view full article